MC

MI Care

Description

MI Care S.A. is a private investment company, incorporated in the Great Duchy of Luxembourg.

Investor Profile

MI Care has made 3 investments, with 0 in the past 12 months and 33% as lead.

Stage Focus

  • Series B (33%)
  • Private Equity (33%)
  • Series Unknown (33%)

Country Focus

  • France (100%)

Industry Focus

  • Medical
  • Pharmaceutical
  • Biotechnology
  • Therapeutics
  • Health Diagnostics
  • Oncology
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does MI Care frequently co-invest with?

Cemag Invest
Europe, Ile-de-France, France, Paris
Co-Investments: 2
IRDI SORIDEC Gestion
Europe, Midi-Pyrenees, France, Toulouse
Co-Investments: 1
I
Asia, Negeri Sembilan, Malaysia, Nilai
Co-Investments: 1
BNP Paribas Développement
Europe, Ile-de-France, France, Paris
Co-Investments: 1
QF
Europe, Vlaams-Brabant, Belgium, Leuven
Co-Investments: 1
Bpifrance
Europe, Ile-de-France, France, Maisons-alfort
Co-Investments: 1
Sham
Europe, Rhone-Alpes, France, Lyon
Co-Investments: 1
IXO Private Equity
Europe, Midi-Pyrenees, France, Toulouse
Co-Investments: 2
Co-Investments: 1
S
Europe, Provence-Alpes-Cote d'Azur, France, Aix-en-provence
Co-Investments: 1

What are some of recent deals done by MI Care?

HalioDx

Marseille, Provence-Alpes-Cote d'Azur, France

HalioDx designs and develops diagnostic tests in oncology utilizing the immune contexture of cancers.

Health DiagnosticsMedicalOncologyPharmaceutical
Series BJan 17, 2018
Amount Raised: $22,533,825
Advicenne

Paris, Ile-de-France, France

Advicenne is a specialty pharmaceutical company dedicated to improving the lives of patients who suffer from rare kidney diseases.

BiotechnologyMedicalPharmaceuticalTherapeutics
Private EquityMar 20, 2017
Amount Raised: $17,179,197
Advicenne

Paris, Ile-de-France, France

Advicenne is a specialty pharmaceutical company dedicated to improving the lives of patients who suffer from rare kidney diseases.

BiotechnologyMedicalPharmaceuticalTherapeutics
Series UnknownMar 20, 2017
Amount Raised: $17,179,197